TCM
Tekla Capital Management Portfolio holdings
AUM
$2.56B
This Quarter Return
-12.46%
1 Year Return
+18.15%
3 Year Return
+62.34%
5 Year Return
+140.22%
10 Year Return
+499.57%
AUM
$2.63B
AUM Growth
+$2.63B
(-2.1%)
Cap. Flow
+$309M
Cap. Flow
% of AUM
11.73%
Top 10 Holdings %
Top 10 Hldgs %
44.7%
Holding
148
New
38
Increased
32
Reduced
10
Closed
13
Top Buys
| 1 |
UnitedHealth
UNH
|
$36.3M |
| 2 |
Biogen
BIIB
|
$33.3M |
| 3 |
Merck
MRK
|
$24.5M |
| 4 |
United Therapeutics
UTHR
|
$24M |
| 5 |
MDCO
Medicines Co
MDCO
|
$23.7M |
Top Sells
| 1 |
CTRX
CATAMARAN CORP COM STK (CDA)
CTRX
|
$26.5M |
| 2 |
Amgen
AMGN
|
$24.3M |
| 3 |
RCPT
RECEPTOS INC COM STK (DE)
RCPT
|
$23.7M |
| 4 |
CELG
Celgene Corp
CELG
|
$23.3M |
| 5 |
ACOR
Acorda Therapeutics, Inc.
ACOR
|
$22.7M |
Sector Composition
| 1 | Healthcare | 85.75% |
| 2 | Real Estate | 3.66% |
| 3 | Financials | 1.38% |
| 4 | Technology | 0.04% |
